Cost-Effectiveness of Surveillance Scanning Strategies after Curative Treatment of Non-Small-Cell Lung Cancer.
Harold B WolffLeonie AlbertsElisabeth A KastelijnSherif Y El SharouniFranz M N H SchramelVeerle M H CoupéPublished in: Medical decision making : an international journal of the Society for Medical Decision Making (2020)
Model simulations suggest that limited CT surveillance scanning after the treatment of primary NSCLC is cost-effective, but the incremental health-benefit remains marginal. However, model simulations do suggest that the guideline strategy is not cost-effective.